LEGN
Legend Biotech CorpNASDAQ
Healthcare • Biotechnology
Updated 11 minutes ago
Coverage limited
Factor tilt: Growth-tilted Mid Cap
$17.88+0.45%
Close Oct 13, 2026
- Market cap
- $3.47B
- 1 month
- -3.5%
- 3 months
- -22.4%
- 1 year
- -43.6%
- 52-week range
- $16.65$36.28
- Dividend
- No dividends on record
- Short interest
- 18.1% of float16.4M shares · settled Sep 30, 2026 · +12.0% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if LEGN is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
40 top institutions tracked
as of 2026-Q2 (filed 2026-09-23)
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: neutral
Last trade: sell 14 days ago
Red flags: 0
Largest 13-F holders · Q2 2026
219 filers reported a long position in LEGN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $840.2M | 29.1M | +13.2% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $235M | 8.1M | +5.9% |
| MONTANOVA CAPITAL, LLC | $204.2M | 7.1M | -6.7% |
| HHLR ADVISORS, LTD. | $172.8M | 6M | Unchanged |
| BlackRock, Inc. | $136.5M | 4.7M | +0.9% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $127.9M | 4.4M | -23.1% |
| GOLDMAN SACHS GROUP INC | $105.8M | 3.7M | +150.1% |
| Point72 Asset Management, L.P. | $88.8M | 3.1M | -20.8% |
| Kynam Capital Management, LP | $86.7M | 3M | +90.4% |
| Assenagon Asset Management S.A. | $55.3M | 1.9M | New |
Get the Full Analysis for LEGN
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.